跳至主要内容
临床试验/NL-OMON36667
NL-OMON36667已完成不适用

Safety and efficacy of a biodegradable stent during neoadjuvant therapy in patients with advanced esophageal cancer. - EsNeBio.

Academisch Medisch Centrum0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * cT1-3 N0-1 M0 esophageal carcinoma.
  • * Scheduled for neoadjuvant chemoradiation therapy prior to esophagectomy.
  • * Dysphagia for solid, semisolid or liquid food (dysphagia score 2, 3, 4).
  • * Age older then 18 years.
  • * Informed consent.

排除标准

  • * Tumor length of more than 10 cm.
  • * Tumor growth within 5 cm of the upper esophageal sphincter.
  • * Tumor extension into the stomach more than 5 cm.
  • * Patients with a poor mental condition or mental retardation, unable to understand the nature and possible consequences of the study or unwilling to undergo follow-up assessments.

研究者

相似试验